About Stead Impact Ventures
Stead Impact Ventures is a venture capital firm founded in 2023. It is primarily based out of United States. As of Dec 2025, Stead Impact Ventures is an active investor, having invested in 9 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and HealthTech. Most recently it participated in the $***** Series A round of MedWatch Technologies Stead Impact Ventures has team of 3 people including 3 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A
Deals in last 12 months
Stead Impact Ventures' List of Top Investments
Stead Impact Ventures has a portfolio of 9 companies. Their most notable investmentis in MedWatch TechnologiesTheir portfolio spans across and United States. They have invested in Enterprise Applications, Life Sciences, HealthTech and 5 other sectors, across stages such as Series A stage. Here is the list of top investments by Stead Impact Ventures:
1. Spinogenix
Developer of therapeutics for brain injury and neurodegenerative diseases. The company is focusing on developing novel molecules that can reverse the synaptic dysfunction induced in neurogenerative disorders. Their molecules would be targeting proteins regulating synapse formation. The company is also focusing on Traumatic Brain Injury.
Key facts about Spinogenix
- Founded Year: 2016
- Location: San Diego (United States)
- Stage: Series B
- Total Funding till date: $19.2M
- Employee Count: 4 as on Aug 31, 2026
- Investors: Stead Impact Ventures and HHS
- Latest Funding Round: Series B, Nov 21, 2025, $*****
- Highlight: Editors' Pick
2. ALZpath
Developer of diagnostic solutions for Alzheimer's Disease. The company offers a novel blood-based biomarker assay for phosphorylated tau 217 (ptau217) that can identify Alzheimer's disease before symptoms appear.
Key facts about ALZpath
- Founded Year: 2020
- Location: Carlsbad (United States)
- Stage: Series A
- Total Funding till date: $8.41M
- Employee Count: 10 as on Aug 31, 2026
- Investors: Stead Impact Ventures and Alzheimer's Drug Discovery
- Latest Funding Round: Series A, Jul 14, 2026, $*****
- Highlight: Editors' Pick
Developer of diagnostics test for detection of Alzheimer's disease. The company is developing a novel family of fluorescent probes to be used as diagnostic agents to image neurodegenerative diseases through an ophthalmic approach using standard technology available in eye care specialist offices.
Key facts about Amydis Diagnostics
- Founded Year: 2013
- Location: San Diego (United States)
- Stage: Series A
- Total Funding till date: $8.69M
- Employee Count: 12 as on Sep 30, 2026
- Investors: NIA, Springboard Enterprises and 4 Others
- Latest Funding Round: Grant (prize money), Sep 09, 2025, $*****
- Highlight: Editors' Pick
Provider of non-invasive wearable device for glucose monitoring. The company offers wearable watch and tools that allow users to continuously adjust their diet and lifestyle in response to their immediate glucose metrics.
Key facts about MedWatch Technologies
- Founded Year: 2022
- Location: United States
- Stage: Series A
- Total Funding till date: $17.6M
- Employee Count: 32 as on Aug 31, 2026
- Investors: Stead Impact Ventures and Black Dog Venture Partners
- Latest Funding Round: Series A, Dec 11, 2025, $*****
- Highlight: Editors' Pick
5. AccuTitle
AccuTitle provides cloud-based agency management software for title agencies. It offers solutions for expense control, customer service, and streamline workflow, data security, and more. Its product includes TitleFusion for data management and MagramFusion for rate & tax calculations. Its partner includes First American Title Insurance Company, Chicago Insurance Copany, Catic Title, and more.
Key facts about AccuTitle
- Founded Year: 2003
- Location: Cherry Hill (United States)
- Stage: Funding Raised
- Employee Count: 70 as on Aug 31, 2026
- Investors: Plexus Capital and Stead Impact Ventures
- Highlight: Editors' Pick
Stead Impact Ventures' Year-on-Year Investment Trends
In 2025, it made 1 investment. Its most recent first time investment was in MedWatch Technologies.Stead Impact Ventures' Investments by Stage
Stead Impact Ventures has made 1 investment in Series A stage with an average round size of $17.6M.Stead Impact Ventures' Investments by Sector
Stead Impact Ventures has a diverse portfolio, with companies operating in the HealthTech, High Tech, Internet of Things - Industry Applications and Life Sciences. Notably, it has invested in 8 Tech companies, 6 Enterprise (B2B) companies, 5 Software companies and at least 2 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
HealthTech | 1 |
High Tech | 1 |
Internet of Things - Industry Applications | 1 |
Life Sciences | 1 |
Note: We have considered here, only first round of investments
Stead Impact Ventures' Investments by Geography
Stead Impact Ventures has made most investments in United States (1).Stead Impact Ventures' recent investments
Stead Impact Ventures has not made any investment in 2026 so far.Here are the most recent investments by Stead Impact Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 11, 2025 | United States | Series A | 5868 | - |
Team profile of Stead Impact Ventures
Stead Impact Ventures has a team of 3 members including 3 Partners located in United States. Stead Impact Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in Stead Impact Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | United States | - | ||
Partner | Scottsdale | - | ||
Partner | - | - |
Recent News related to Stead Impact Ventures
•
AP Stead Impact Ventures Leads $15M Series A for MedWatch TechnologiesBakersfield•Jan 14, 2026•Stead Impact Ventures, MedWatch Technologies
